Hereditary Hemorrhagic Telangiectasia (HHT)

HHT is a genetic condition that causes enlargements and tangles of veins and arteries (telangiectasias) and other malformations of the blood vessels. These can occur in the brain, lungs, digestive system, skin or other organs. HHT is somewhat rare, affecting approximately 1 in 5,000 people. It does not occur more frequently among people of any gender or racial or ethnic background. The main symptoms of hereditary hemorrhagic telangiectasia involve blood vessel malformations that can cause bleeding. Telangiectasias and other AVMs in people with HHT can form from birth until adulthood, and may occur in several organs of the body.

 

  • Patient Support and Education
  • Care Coordination
  • Advocacy Efforts

Related Conference of Hereditary Hemorrhagic Telangiectasia (HHT)

January 12-13, 2026

12th International Heart Conference

Dubai, UAE
March 18-19, 2026

15th World Heart Congress

Paris, France
March 23-24, 2026

37th Annual Cardiologists Conference

London, UK
March 23-24, 2026

41st World Cardiology Conference

London, UK
April 08-29, 2026

9th Annual Heart Rhythm Conference

Vienna, Austria
April 13-14, 2026

9th World Heart and Brain Conference

Tokyo, Japan
April 15-16, 2026

8th World Heart Congress

Tokyo, Japan
May 14-15, 2026

5th International Conference on Cardiology

Rome, Italy
May 21-22, 2026

15th World Congress on Cardiology

London, UK
June 15-16, 2026

7th European Summit on Cardiology Research

Zurich, Switzerland
July 29-30, 2026

30th World Cardiology Conference

Paris, France
August 17-18, 2026

4th International Conference on World Heart Care

Toronto, Canada
August 24-25, 2026

15th World Heart Congress

London, UK
August 27-28, 2026

40th European Cardiology Conference

Berlin, Germany

Hereditary Hemorrhagic Telangiectasia (HHT) Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in